Cargando…
The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells
MEK Partner 1 (MP1 or MAPKSP1) is a scaffold protein that has been reported to function in multiple signaling pathways, including the ERK, PAK and mTORC pathways. Several of these pathways influence the biology of breast cancer, but MP1’s functional significance in breast cancer cells has not been i...
Autores principales: | Marina, Mihaela, Wang, Limin, Conrad, Susan E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406937/ https://www.ncbi.nlm.nih.gov/pubmed/22776333 http://dx.doi.org/10.1186/1478-811X-10-18 |
Ejemplares similares
-
Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer
por: Naderi, Ali, et al.
Publicado: (2011) -
Anticipatory Estrogen Activation of the Unfolded Protein Response is Linked to Cell Proliferation and Poor Survival in Estrogen Receptor α Positive Breast Cancer
por: Andruska, Neal, et al.
Publicado: (2014) -
Vessel size as a marker of survival in estrogen receptor positive breast cancer
por: Milosevic, Vladan, et al.
Publicado: (2023) -
Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor
por: Ellison-Zelski, Stephanie J, et al.
Publicado: (2010) -
Differential requirement for MEK Partner 1 in DU145 prostate cancer cell migration
por: Park, Electa R, et al.
Publicado: (2009)